Abstract
The regular use of DSCG and β-stimulant inhalation therapy for the 31 patients with severe, intractable bronchial asthma was investigated. The mixture of DSCG and β-stimulant inhalation solution was administerd once to three times a clay by use of electric neblizer. This trial was evaluated by the frequency and the severity of a bronchial asthma attack. The clinical improvement was expressed by the terms, “no change”, “fair”, “good” and “excellent”. During the first month of the treatment, this trial provided good to excellent clinical improvement in 67.7% of the patients, and excellent improvement in 38.7% of the patients. Moreover, the effectiveness of this trial was confirmed by the findings that, compared with the previous year, the frequency and the severity of bronchial asthma attacks were markedly to moderately reduced in 46.7% of the patients, and 76.2% of all the patients have gained good to excellent improvement. Thus, the regular inhalation of the mixture of DSCG and β-stimulant proved to be useful for the prophylaxis of the bronchial asthma attack, and also useful for blocking the on-going severity of bronchial asthma.
